We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Poor Sleep Quality Increases Cancer Aggression

By HospiMedica International staff writers
Posted on 16 Feb 2014
Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages (TAMs), according to a new study.

Researchers at the University of Chicago (IL, USA) and the University of Louisville (KY, USA) fragmented the sleep of mice by waking them up every two minutes during sleep for a period of week, before injecting them with cancerous cells. More...
All mice developed tumors within twelve days of injection and their tumors were measured after four weeks. The results showed that there was an increase in tumor size, weight, and invasiveness in the fragmented sleep mice, compared to control animals.

Furthermore, the sleep-deprived mice had increased counts of TAMs, immune cells that respond differently to cancer depending on the chemical signals they receive. While M1 TAMs promote an immune response and eliminate tumor cells, M2 TAMs suppress an immune response and encourage tumor growth. The fragmented sleep induced a TAM polarity shift so that there was more M2 expression than M1 expression in tumors, which appears to be triggered by three key molecules: upstream signaling by toll-like receptor 4 (TLR4), and downstream signals by MYD88 and TRIF channels.

To examine the impact of the three signaling paths, the researchers injected tumor cells into a series of mice that were unable to produce one of these three proteins and subjected them to fragmented sleep. Tumor growth was slightly reduced in mice lacking MYD88 or TRIF, but in mice lacking TLR4, tumor growth was no greater than in mice with undisturbed sleep, indicating that TLR4 is a major contributor to tumor growth in fragmented sleep. The study was published online on January 21, 2014, in Cancer Research.

“When tumor cells were implanted in the thigh muscle, which should help contain growth, the tumors were much more aggressive and invaded surrounding tissues in mice with disrupted sleep,” said senior author David Gozal, MD, chairman of pediatrics at the UC Comer Children’s Hospital. “In that setting, tumors are usually encased by a capsule of surrounding tissue, like a scar. They form little spheres, with nice demarcation between cancerous and normal tissue. But in the fragmented-sleep mice, the tumors were much more invasive. They pushed through the capsule. They went into the muscle, into the bone. It was a mess.”

Related Links:

University of Chicago
University of Louisville



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.